Adverse events of the BNT162b2 vaccine in patients with AIIRD and controls
Adverse event | After the first vaccine dose | After the second vaccine dose | ||||||
Controls n=121 | AIIRD n=673 | Controls n=121 | AIIRD n=670 | |||||
Local reactions, n (%) | ||||||||
Pain | 69 (57.02) | 377 (56.02) | 51 (42.5) | 314 (46.87) | ||||
Erythema | 4 (3.31) | 12 (1.78) | 6 (5) | 10 (1.49)* | ||||
Swelling | 6 (4.69) | 18 (2.68) | 6 (5) | 15 (2.24) | ||||
Pruritus | 3 (2.48) | 8 (1.19) | 2 (1.67) | 4 (0.6) | ||||
Tingling | 7 (5.79) | 3 (0.45)** | 1 (0.83) | 0 | ||||
Systemic reactions, n (%) | ||||||||
Fever ≥38.0°C | 1 (0.83) | 8 (1.19) | 6 (4.96) | 35 (5.24) | ||||
Nausea | 0 | 7 (1.04) | 2 (1.67) | 14 (2.09) | ||||
Vomiting | 1 (0.83) | 3 (0.45) | 0 | 1 (0.15) | ||||
Rhinorrhea | 3 (2.48) | 0 * | 0 | 1 (0.15) | ||||
Cough | 1 (0.83) | 2 (0.3) | 0 | 1 (0.15) | ||||
Myalgia | 5 (4.13) | 25 (3.71) | 21 (17.36) | 63 (9.4)* | ||||
Arthralgia | 1 (0.83) | 23 (3.42) | 6 (4.96) | 49 (7.32) | ||||
Chills | 2 (1.65) | 13 (1.93) | 21 (17.36) | 60 (8.96)* | ||||
Malaise | 1 (0.83) | 13 (1.93) | 21 (17.36) | 53 (7.91)* | ||||
Headache | 7 (5.97) | 47 (6.98) | 18 (14.88) | 85 (12.69) | ||||
Allergic reaction | 0 | 0 | 0 | 1 (0.15) | ||||
Lethargy | 6 (4.96) | 36 (5.35) | 10 (8.26) | 90 (13.49) | ||||
Worsening of rheumatological symptoms | NA | 17 (2.53) | NA | 12 (1.79) | ||||
Other symptoms, n | Dizziness | 2 | Throat pain | 5 | Weakness | 3 | Weakness | 28 |
Numbness | 1 | Arm numbness | 5 | Dizziness | 1 | Dizziness | 11 | |
Throat pain | 1 | Dizziness | 4 | Numbness | 3 | Throat pain | 6 | |
Chest pain | 1 | Weakness | 4 | Facial pain | 1 | Excessive sweating | 3 | |
Rash | 2 | Chest pain | 2 | Pericarditis | 1 | |||
Flu-like | 2 | Chest pain | 1 | |||||
Diarrhoea | 2 | Local lymphadenopathy | 2 | |||||
Pruritus | 2 | Vaginal bleeding | 2 | |||||
Palpitations | 2 | Lack of appetite | 2 | |||||
Uveitis | 1 | Diarrhoea | 2 | |||||
Herpes Labialis | 1 | High blood pressure | 2 | |||||
Other | 3 | Herpes zoster | 6 | |||||
Uveitis | 2 | |||||||
Other | 7 | |||||||
Death | 0 | 0 | 0 | 2 (0.3) |
*p≤0.05; **p≤0.0001.
AIIRD, autoimmune inflammatory rheumatic diseases.